Curriculum Vitae

DR. LOH THIAN CHEE

Medical Lecturer
  • Department of Medicine
    Faculty of Medicine
  • tcloh
  • 0379492299

AREAS OF EXPERTISE

  • RESPIRATORY DISEASES

ACADEMIC QUALIFICATION

  • MRCP
    Royal College of Physicians of Edinburgh, United Kingdom
  • MBBS, (Medicine and Surgery)
    Otago University, New Zealand

ADMINISTRATIVE DUTIES

  • Coordinator
    06 Jul 2022 - 30 Jun 2024 (Department of Medicine, Faculty of Medicine)
  • Committee Members
    11 Jan 2022 - 31 Jul 2022 (Department)
  • Coordinator
    07 Mar 2019 - 31 Dec 2020 (University Malaya)
  • Member of RED COPD team
    13 Sep 2019 - 31 Dec 2020 (University Malaya)
  • Menjalankan Fungsi Sebagai Penyelaras Program
    04 Sep 2019 - 02 Nov 2019 (National)

MEMBERSHIPS

  • MEMBER, MEMBER
    2023 to 2024 (International)
  • NSR IN SUBSPECIALTY (RESPIRATORY MEDICINE), MEMBER
    2022 to present (National)
  • MEMBER, MEMBER
    2019 to 2024 (National)
  • MEMBER, MEMBER
    Since 2019 (National)
  • MEMBER, MEMBER
    2022 to 2023 (International)
  • MEMBER, MEMBER
    2022 to 2022 (International)

AWARD AND STEWARDSHIP

  • Organisor and Fascilitator of Breathe EaSY programme nurse educator training programme
    Department of Medicine , 2020 (University)
  • Facilitator and resource person
    MERDU, 2019 (University)
  • Notable contribution as an invited speaker
    UMMC TB committee, 2019 (University)
  • Training on CPG: Management of diabetes in pregnancy
    Obstetrics and Gynaecology, UMMC, 2018 (University)

PUBLICATIONS

Article in Journal
WoS
  1. Soo, Chun Ian; Poon, Khai Vern; Ayub, Atiqah; You, Hui Wen; Tan, Cai Xian; Loh, Jia Juin Kenneth; Eng, Chai Hui Carolyn; Sia, Leng Cheng; Ibrahim, Nur Husna; Chin, Ka Kiat; Loh, Thian Chee; Munusamy, Vijayan; Poh, Mau Ern; Tan, Jun Liang; Pang, Yong Kek; Liam, Chong Kin; Wong, Chee Kuan (2023). Methyprednisolone versus dexamethasone for severe COVID-19 infection: A retrospective comparative analysis of our early experience, RESPIROLOGY. 28, 92-92
  2. Sia, L. C.; Wong, C. K.; Ooi, N. Z. M.; Chan, W. Y.; Pang, Y.; Liam, C. K.; Soo, C. I.; Tan, J. L.; Poh, M. E.; Chin, K. K.; Loh, T. C.; Ibrahim, N. H.; Munusamy, V. (2022). Persistent respiratory failure in severe COVID-19 patients - A tertiary centre experience in Kuala Lumpur, Malaysia., EUROPEAN RESPIRATORY JOURNAL. 60. doi:10.1183/13993003.congress-2022.2671
  3. Liam, C. K.; Yew, C. Y.; Pang, Y. K.; Wong, C. K.; Poh, M. E.; Tan, J. L.; Soo, C. I.; Loh, T. C.; Chin, K. K.; Munusamy, V.; Ibrahim, N. H. (2021). Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers, JOURNAL OF THORACIC ONCOLOGY. 16(10), S1141-S1142
  4. Chin, Ka Kiat; Loh, Thian Chee; Chai, Chee Shee; Tan, Jiunn Liang; Poh, Mau Ern; Wong, Chee Kuan; Pang, Yong Kek; Liam, Chong Kin (2019). BALLOON DILATATION IN POST TUBERCULOSIS BRONCHIAL STENOSIS, RESPIROLOGY. 24, 227-228
  5. Poh, M. E., Liam, C. K., Mun, K. S., Chai, C. S., Wong, C. K., Tan, J. L., . . . Chin, K. K. (2019). Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic Cancer, 10(9), 1841-1845. doi: 10.1111/1759-7714.13156
ESCI
  1. Soo, Chun Ian; Ong, Diana Bee-Lan; Chin, Ka Kiat; Sia, Leng Cheng; Munusamy, Vijayan; Ibrahim, Nur Husna; Loh, Thian Chee; Tan, Jiunn Liang; Poh, Mau Ern; Wong, Chee Kuan; Pang, Yong Kek; Liam, Chong Kin (2023). Pathological complete response in an advance stage IIIB non-small cell lung cancer secondary to neoadjuvant osimertinib targeted therapy: A case report and review of literature, RESPIROLOGY CASE REPORTS. 11(7). doi:10.1002/rcr2.1181
  2. Loh, Thian Chee; Pang, Yong Kek; Liam, Chong Kin; Chew, Man Fong; Tan, Jiunn Liang (2022). Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report, RESPIROLOGY CASE REPORTS. 10(10). doi:10.1002/rcr2.1030
Scopus
  1. Loh T.C., Pang Y.K., Liam C.K., Chew M.F., Tan J.L. (2022). Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report, Respirology Case Reports. 10(10). doi:10.1002/rcr2.1030
  2. Poh M.E., Liam C.K., Mun K.S., Chai C.S., Wong C.K., Tan J.L., Loh T.C., Chin K.K. (2019). Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy, Thoracic Cancer. 10(9), 1841-1845. doi:10.1111/1759-7714.13156
Others
  1. Poh, M. E., Liam, C. K., Mun, K. S., Chai, C. S., Wong, C. K., Tan, J. L., Loh, T.C & Chin, K. K. (2019). Epithelial to mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic cancer.
Article in Proceeding
  1. P1 66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report. (2021). Respirology (Carlton, Vic.), 26(S3), 100 100.

RESEARCH PROJECT

National
  1. 2022 - 2024, Others MOHE - Top 100 (IIRG)-FNW
    Elucidation Of Surface Proteins From Plasma-derived Exosomes As Novel Candidate Biomarkers For Lung Cancer Early Detection ( Co-Researcher)
  2. 2024 - 2024, RU Geran - UMCares
    FUTUREGUARD: YOUTH DISASTER PREPAREDNESS INITIATIVE ( Co-Researcher)
  3. 2021 - 2028, Merck Sharp & Dohme (M) Sdn. Bhd.
    A Phase 2, Multicenter, Randomized Study to Compare the Efficacy and Safety of MK-7684A or MK-7684A Plus Docetaxel Versus Docetaxel Monotherapy in the Treatment of Participants With Metastatic Non-small Cell Lung Cancer With Progressive Disease After Treatment With a Platinum Doublet Chemotherapy and Immunotherapy ( Co-Researcher)
  4. 2021 - 2028, MERCK SHARP & DOHME (M) SDN. BHD.
    A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF MK-7684 WITH PEMBROLIZUMAB AS A CO-FORMULATION (MK-7684A) VERSUS PEMBROLIZUMAB MONOTHERAPY AS FIRST LINE TREATMENT FOR PARTICIPANTS WITH PD-L1 POSITIVE (TPS 1%) METASTATIC NON-SMALL CELL LUNG CANCER ( Co-Researcher)
  5. 2021 - 2024, Checkpoint Therapeutics, Inc.
    A Randomized, Open-Label, Phase 3 Study of Cosibelimab (CK-301) in Combination with Platinum+Pemetrexed Chemotherapy in Subjects with First-Line Metastatic Non-squamous Non-Small Cell Lung Cancer ( Co-Researcher)
  6. 2020 - 2023, Novartis Corporation (M) Sdn. Bhd.
    A randomized, open label, multicenter phase II study evaluating the efficacy and safety of capmatinib (INC280) plus pembrolizumab versus pembrolizumab alone as first line treatment for locally advanced or metastatic non-small cell lung cancer with PD-L1, 50%. ( Co-Researcher)
  7. 2021 - 2023, Endeavor Biomedicines (Australia) Pty. Ltd
    A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in subjects with Idiopathic Pulmonary Fibrosis (IPF) ( Co-Researcher)
  8. 2019 - 2022, Prestige BioPharma Pte. Ltd.
    A Randomized, Double-blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin in patients with Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer ( Co-Researcher)
  9. 2021 - 2022, Roche (M) Sdn. Bhd.
    A Prospective, Multicentre, Non-Interventional Genomic Profiling Study in Subjects with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Using Foundation Medicine ( Co-Researcher)
  10. 2019 - 2019, NONE
    Asthma in working adults; A study on the experiences and challenges faced ( Principal Investigator(PI))

PAPER PRESENTED

INVITED SPEAKER
  1. Do I have OSA?, Sleep Hygiene, Faculty of Medicine UM (University) (20 Sep 2023 - 20 Sep 2023)
  2. Latest advancement in the management of COPD, Respiratory Scientific Exchange Meeting - UMMC, Astra Zeneca Sdn. Bhd (University) (01 Sep 2023 - 01 Sep 2023)
  3. Clinical approach in management of moderate asthma: what does GINA 2023 recommends?, MOE summit - meet the grandmasters, Astra Zeneca Sdn. Bhd. (National) (23 Jul 2023 - 23 Jul 2023)
  4. The Road Not Taken:Track 1 or Track 2?Which ICS/LABA to choose?, UKMMC respiratory update, Respiratory Unit UKMMC (National) (15 Jul 2023 - 15 Jul 2023)
  5. Approach to asthma & COPD in primary care, RESPIRATORY UPDATES FOR PRIMARY CARE 2023, DHPL Malaysia Sdn Bhd (National) (03 Jun 2023 - 03 Jun 2023)
  6. SMARTer Approach in Asthma Management: The GINA Perspective, START NOW for a Better TOMORROW, AstraZeneca Sdn Bhd (National) (20 May 2023 - 20 May 2023)
  7. Why Medicine? - The World of Endless Possibilities, An Insight Into Medicine Universiti of Malaya 2023, Baktisiswa 2023 University of Malaya Medical Society University of Malaya (University) (19 Mar 2023 - 19 Mar 2023)
  8. Management of AECOPD, RED COPD 2.0 Seminar, NURSING DEVELOPMENT, NURSING DEPARTMENT AND TRAINING DIVISION, DEPARTMENT OF PROFESSIONAL DEVELOPMENT AND MEDICAL DEVELOPMENT (University) (09 Feb 2023 - 09 Feb 2023)
EVENT ORGANISER
  1. Asthma education, inhaler techniques, Breathe EaSY programme nurse educator training course , Department of Nursing, Department of Medicine (Respiratory Unit) (Others) (14 Sep 2020 - 15 Sep 2020)
POSTER PRESENTER
  1. Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report, 25th congress of the Asian Pacific Society of Respirology , APSR (International) (20 Nov 2021 - 21 Nov 2021)
  2. EFFECTIVENESS OF DIABETES ONE STOP CENTRE (DOSC) IN IMPROVING GLYCAEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A SINGLE CENTRE 6 MONTHS EXPERIENCE, Malaysian Endocrine and Metabolic Society Annual Conference s 9th Session (MAC9), Malaysian Endocrine and Metabolic Society (University) (04 May 2018 - 06 May 2018)
PRESENTER
  1. Management of AECOPD-, COURSE FOR RE-ENGINEERED DISCHARGE IN UMMC (RED) TRAINER, PPUM (Respiratory Unit) (University) (07 Nov 2019 - 07 Nov 2019)
  2. How to monitor for and manage the side effects of anti - TB treatment on the eye , A practical approach to the management of patients with tuberculosis (TB): a case - based TB workshop, UMMB TB committee (University) (24 Oct 2019 - 24 Oct 2019)
OTHERS
  1. Why you would choose a combination approach (EGFR TKI + chemotherapy/ anti angiogenic) for the treatment of EGFR + NSCLC?, EGFR ECHO (EGFR Excellence in Communication of Healthcare Outcomes), Pfizer Sdn. Bhd. (International) (20 Dec 2019 - 20 Dec 2019)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2023) Journal Article Review, International, (Reviewer)
  2. (2023) Journal Article Review, International, (Reviewer)
  3. (2023) Journal Article Review, International, (Reviewer)
  4. (2023) Assessor for Research Project Proposal, University, (Internal Assessor)
  5. (2023) Journal Article Review, International, (Reviewer)
  6. (2023) Journal Article Review, International, (Reviewer)
  7. (2020) Breathe EaSY programme , (Proect leader)
Contribution to external organisation
  1. (2024) Chairperson, University, (Resource Person)
  2. (2023) Trainer, National, (Resource Person)
  3. (2023) Scientific Committee, University, (Resource Person)
  4. (2023) Expert Advisor, National, (Expert Advisor)
  5. (2020) Breathe EaSY Programme , UMMC

SUPERVISION

Postgraduate Student
  1. (2024) : DIAGNOSTIC AND CLINICAL UTILITY OF AURAMINE O SMEAR MICROSCOPY FOR THE DETECTION OF NONTUBERCULOUS MYCOBACTERIA IN THE CLINICAL SAMPLES OF ADULT PATIENTS: A 5-YEAR RETROSPECTIVE STUDY (2018-2022), ONG LEONG TUNG
Under Graduate Students
  1. (2019) UMMP STAGE 3.1, COHORT 2017, POSTING B (02 DECEMBER 2019 - 31 JANUARY 2020)
  2. (2018) Stage 1 Block 5 Respiratory Sciences Timetable (Cohort 2018)
  3. (2018) Pre-Internship Programme (PRINT) Cohort 2014

SOCIAL RESPONSIBILITY ACTIVITIES

  • Speaker, (16 Nov 2022 - 16 Dec 2022) (University)
  • Medical Consultant, (01 Jun 2022 - 31 Dec 2022) (National)
  • Seminar Respiratory (Nursing): Pneumonia, (19 Aug 2019 - 19 Aug 2019)
  • St John Pahang Advance First Aid Examination, (20 Jan 2019 - 20 Jan 2019)